Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2019

Nilsson Martin P, Nilsson Erik D, Silfverberg Barbro, Borg Åke, Loman Niklas

Abstract excerpt

PURPOSE: This study aimed to evaluate predictors of testing uptake among unselected breast cancer patients who were offered germline BRCA1/2 testing in a prospective study. METHODS: Pretest information was provided by a standardized invitation letter instead of in-person counseling. Data was abstracted from medical records. Using multivariate logistic regressions, predictors of testing uptake were analyzed....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to Europe

Share to Genetic Counseling

Share to Germ-Line Mutation

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 29875420
DOI: 10.1038/s41436-018-0021-9

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake.PMID 29875420Read ↗

Obstacles in genetic testing for germline BRCA1/2 pathogenic mutations in patients with primary breast and ovarian cancer in Switzerland.Semantic proximity Read ↗

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.Semantic proximity Read ↗

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.Semantic proximity Read ↗

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast CancerSemantic proximity Read ↗

Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results.Semantic proximity Read ↗

The Impact of Mental Illness on Uptake of Genetic Counseling for Hereditary Breast Cancer and Ovarian Cancer in a Multiethnic Cohort of Breast Cancer Patients.Semantic proximity Read ↗

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.Semantic proximity Read ↗

Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.Semantic proximity Read ↗

Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast CancerSemantic proximity Read ↗

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity Read ↗

BRCA-Related Cancer Genetic Counseling is Indicated in Many Women Seeking Primary Care.Semantic proximity Read ↗

Uptake rates for breast cancer genetic testing: a systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.